Bharat Biotech gets approval for phase 2 clinical trials for potential COVID – 19 vaccine Covaxin

Hyderabad based Bharat Biotech receives an approval from the Central Drugs Standard Control Organization (CDSCO) backed up by Directorate General of Health Services for conducting Phase 2 clinical trials for Coronavirus vaccine – Covaxin, scheduled from Monday (September 7). The Joint Drugs Controller of India, Dr. Eswara Reddy has issued a letter to Bharat Biotech…

Read More
error: Content is protected !!